Pub Date : 2025-08-01Epub Date: 2025-03-05DOI: 10.1080/13645706.2025.2473587
Ilaria Benzoni, Martina Fricano, Jessica Borali, Martina Bonafede, Andrea Celotti, Antonio Tarasconi, Valerio Ranieri, Luigi Totaro, Luca Mattia Quarti, Arianna Dendena, Giulia Grizzi, Maria Bonomi, Roberto Grassia, Barbara Frittoli, Gian Luca Baiocchi
Background: The spread of colorectal cancer screening has increased the percentage of patients with early-stage rectal cancer; at least 30% of patients are diagnosed with a clinical-stage cT1 or pT1 after endoscopic excision. In this subgroup of patients, the real advantage of total mesorectal excision (TME) over local excision (LE) is the ability to remove mesorectal nodes, which are metastatic in less than 20% of cases.
Method: To solve the unmet need for accurate nodal staging in patients with cT0/cT1, cN0 rectal cancer, we designed a pilot study that associates LE with mesorectal fluorescence-guided nodal sampling. From November 2018 to November 2023, we enrolled a total of ten patients with T1N0M0 rectal cancer. After extensive staging and adequate information, patients underwent endoscopic indocyanine green (ICG) infiltration and transanal local excision associated with laparoscopic fluorescence-guided mesorectal nodal sampling.
Results: After a median follow-up of 24 months (range 1-63 months), no case of local or nodal recurrence was observed. All patients were spared from ostomy and lower anterior resection syndrome.
Conclusions: In selected cases of cT0-1cN0 rectal cancer, transanal local excision plus ICG lymph nodal sampling is a feasible surgical option that increases the rate of organ preservation. Further studies are needed to identify the patients most likely to benefit from this minimally invasive strategy.
{"title":"Fluorescence-guided mesorectal nodes harvesting associated with local excision for early rectal cancer: technical notes.","authors":"Ilaria Benzoni, Martina Fricano, Jessica Borali, Martina Bonafede, Andrea Celotti, Antonio Tarasconi, Valerio Ranieri, Luigi Totaro, Luca Mattia Quarti, Arianna Dendena, Giulia Grizzi, Maria Bonomi, Roberto Grassia, Barbara Frittoli, Gian Luca Baiocchi","doi":"10.1080/13645706.2025.2473587","DOIUrl":"10.1080/13645706.2025.2473587","url":null,"abstract":"<p><strong>Background: </strong>The spread of colorectal cancer screening has increased the percentage of patients with early-stage rectal cancer; at least 30% of patients are diagnosed with a clinical-stage cT1 or pT1 after endoscopic excision. In this subgroup of patients, the real advantage of total mesorectal excision (TME) over local excision (LE) is the ability to remove mesorectal nodes, which are metastatic in less than 20% of cases.</p><p><strong>Method: </strong>To solve the unmet need for accurate nodal staging in patients with cT0/cT1, cN0 rectal cancer, we designed a pilot study that associates LE with mesorectal fluorescence-guided nodal sampling. From November 2018 to November 2023, we enrolled a total of ten patients with T1N0M0 rectal cancer. After extensive staging and adequate information, patients underwent endoscopic indocyanine green (ICG) infiltration and transanal local excision associated with laparoscopic fluorescence-guided mesorectal nodal sampling.</p><p><strong>Results: </strong>After a median follow-up of 24 months (range 1-63 months), no case of local or nodal recurrence was observed. All patients were spared from ostomy and lower anterior resection syndrome.</p><p><strong>Conclusions: </strong>In selected cases of cT0-1cN0 rectal cancer, transanal local excision plus ICG lymph nodal sampling is a feasible surgical option that increases the rate of organ preservation. Further studies are needed to identify the patients most likely to benefit from this minimally invasive strategy.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"290-296"},"PeriodicalIF":2.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143557330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The optimal reconstruction route after esophagectomy remains controversial. The retrosternal route has the advantage of a lower risk of fatal complications. However, the blind maneuver to create a retrosternal route may cause bleeding and pleural injury. Herein, we report a novel robotic technique for creating a retrosternal route.
Methods: This study included 43 consecutive patients with esophageal cancer who underwent robot-assisted minimally invasive esophagectomy with robotic retrosternal route reconstruction between April 2021 and December 2023. Clinicopathological findings and perioperative outcomes, including the time required to create the retrosternal route, were retrospectively analyzed. The creation times were also compared among surgeons.
Results: The median age and body mass index of the patients were 68 years (range: 46-80) and 21.4 kg/m2 (range: 16.6-30.2 kg/m2), respectively. Twenty-six patients (60%) received neoadjuvant chemotherapy. The median time to create the retrosternal route was nine minutes (range, 5-14 min). No cases showed pleural injury or postoperative hemorrhage associated with this procedure. There was no significant difference in the time taken to create the retrosternal route between the four surgeons (p = 0.434).
Conclusions: Robotic creation of a retrosternal route for gastric conduit reconstruction is simple, easy to learn, and results in a safe and feasible procedure.
{"title":"A novel robotic technique for creating the retrosternal route in gastric conduit reconstruction.","authors":"Toshikatsu Tsuji, Noriyuki Inaki, Kenta Doden, Saki Hayashi, Hiroto Saito, Takahisa Yamaguchi, Daisuke Yamamoto, Koichi Okamoto, Hideki Moriyama, Jun Kinoshita","doi":"10.1080/13645706.2025.2475122","DOIUrl":"10.1080/13645706.2025.2475122","url":null,"abstract":"<p><strong>Background: </strong>The optimal reconstruction route after esophagectomy remains controversial. The retrosternal route has the advantage of a lower risk of fatal complications. However, the blind maneuver to create a retrosternal route may cause bleeding and pleural injury. Herein, we report a novel robotic technique for creating a retrosternal route.</p><p><strong>Methods: </strong>This study included 43 consecutive patients with esophageal cancer who underwent robot-assisted minimally invasive esophagectomy with robotic retrosternal route reconstruction between April 2021 and December 2023. Clinicopathological findings and perioperative outcomes, including the time required to create the retrosternal route, were retrospectively analyzed. The creation times were also compared among surgeons.</p><p><strong>Results: </strong>The median age and body mass index of the patients were 68 years (range: 46-80) and 21.4 kg/m2 (range: 16.6-30.2 kg/m2), respectively. Twenty-six patients (60%) received neoadjuvant chemotherapy. The median time to create the retrosternal route was nine minutes (range, 5-14 min). No cases showed pleural injury or postoperative hemorrhage associated with this procedure. There was no significant difference in the time taken to create the retrosternal route between the four surgeons (<i>p</i> = 0.434).</p><p><strong>Conclusions: </strong>Robotic creation of a retrosternal route for gastric conduit reconstruction is simple, easy to learn, and results in a safe and feasible procedure.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"303-309"},"PeriodicalIF":2.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-28DOI: 10.1080/13645706.2025.2539473
Masao Takahashi, Ken Nakazawa, Yoko Usami, Kaho Mori, Jun Suzuki, Shiho Asami, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba
Background: A new type of percutaneous gastrostomy device, designed not to use any guidewires during the procedure, is now available. This study aimed to evaluate the feasibility and clinical outcomes of this device for computer tomography-guided percutaneous gastrostomy (CT-PG).
Methods: Retrospective, single-center study reviewed patients who underwent CT-PG with the non-guidewire gastrostomy device between September 2020 and August 2024. CT-PG was indicated only for patients who had previously experienced failure of percutaneous endoscopic gastrostomy (PEG). The study assessed technical outcomes during the CT-PG procedure with the non-guidewire device and clinical outcomes following the CT-PG.
Results: A total of 24 patients were enrolled in this study. Technical success was achieved in all cases. The mean procedural time was 30.2 min, and the mean radiation dose was 548.9 mGy·cm. Minor hematoma in the greater omentum occurred in four cases, but none of them required transfusion or invasive intervention. No major complications were observed. The mean follow-up period after CT-PG was 253.6 days, with no gastrostomy-related complications affecting its function as a feeding route.
Conclusions: The non-guidewire gastrostomy device is a feasible option for gastrostomy formation under CT fluoroscopy, offering favorable clinical outcomes.
{"title":"Feasibility and clinical outcomes of CT-guided percutaneous gastrostomy with non-guidewire device.","authors":"Masao Takahashi, Ken Nakazawa, Yoko Usami, Kaho Mori, Jun Suzuki, Shiho Asami, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba","doi":"10.1080/13645706.2025.2539473","DOIUrl":"https://doi.org/10.1080/13645706.2025.2539473","url":null,"abstract":"<p><strong>Background: </strong>A new type of percutaneous gastrostomy device, designed not to use any guidewires during the procedure, is now available. This study aimed to evaluate the feasibility and clinical outcomes of this device for computer tomography-guided percutaneous gastrostomy (CT-PG).</p><p><strong>Methods: </strong>Retrospective, single-center study reviewed patients who underwent CT-PG with the non-guidewire gastrostomy device between September 2020 and August 2024. CT-PG was indicated only for patients who had previously experienced failure of percutaneous endoscopic gastrostomy (PEG). The study assessed technical outcomes during the CT-PG procedure with the non-guidewire device and clinical outcomes following the CT-PG.</p><p><strong>Results: </strong>A total of 24 patients were enrolled in this study. Technical success was achieved in all cases. The mean procedural time was 30.2 min, and the mean radiation dose was 548.9 mGy·cm. Minor hematoma in the greater omentum occurred in four cases, but none of them required transfusion or invasive intervention. No major complications were observed. The mean follow-up period after CT-PG was 253.6 days, with no gastrostomy-related complications affecting its function as a feeding route.</p><p><strong>Conclusions: </strong>The non-guidewire gastrostomy device is a feasible option for gastrostomy formation under CT fluoroscopy, offering favorable clinical outcomes.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-6"},"PeriodicalIF":2.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-23DOI: 10.1080/13645706.2025.2537927
Yaozong Huang, Fan Zhang, Fanyang Zhang, Xin Wu, Yufei Xinye
Background: In minimally invasive surgery, designing puncture needles with customizable structures to achieve personalized puncture performance is a significant challenge. Existing reverse design methods struggle to capture the complex nonlinear behavior of needle-tissue interactions.
Methods: This study proposes a machine-learning-based reverse design method aimed at achieving precise customization of needle mechanical behavior. We developed a rapid reverse design framework integrating machine learning and finite element analysis, capable of directly generating optimal structural parameters from target puncture force-penetration depth curves. Through training on large-scale finite element simulation data, deep learning neural network models captured the complex mapping relationship between needle structure and mechanical response.
Results: In rigorous cross-validation, the prediction results showed normalized root mean square errors (NRMSE) of 0.06381 and 0.06234 compared to the target curves and finite element analysis, respectively. The model achieved 98.2% classification accuracy for curve types, with loss functions converging to optimal values after sufficient training epochs.
Conclusion: This approach demonstrates high accuracy and robustness in needle-design customization. It not only opens new avenues for rapid, customized design of puncture needles but also provides an innovative paradigm for intelligent design of complex medical devices, potentially advancing precision medicine technologies and shortening design cycles.
{"title":"Machine learning-driven inverse design of puncture needles with tailored mechanics.","authors":"Yaozong Huang, Fan Zhang, Fanyang Zhang, Xin Wu, Yufei Xinye","doi":"10.1080/13645706.2025.2537927","DOIUrl":"https://doi.org/10.1080/13645706.2025.2537927","url":null,"abstract":"<p><strong>Background: </strong>In minimally invasive surgery, designing puncture needles with customizable structures to achieve personalized puncture performance is a significant challenge. Existing reverse design methods struggle to capture the complex nonlinear behavior of needle-tissue interactions.</p><p><strong>Methods: </strong>This study proposes a machine-learning-based reverse design method aimed at achieving precise customization of needle mechanical behavior. We developed a rapid reverse design framework integrating machine learning and finite element analysis, capable of directly generating optimal structural parameters from target puncture force-penetration depth curves. Through training on large-scale finite element simulation data, deep learning neural network models captured the complex mapping relationship between needle structure and mechanical response.</p><p><strong>Results: </strong>In rigorous cross-validation, the prediction results showed normalized root mean square errors (NRMSE) of 0.06381 and 0.06234 compared to the target curves and finite element analysis, respectively. The model achieved 98.2% classification accuracy for curve types, with loss functions converging to optimal values after sufficient training epochs.</p><p><strong>Conclusion: </strong>This approach demonstrates high accuracy and robustness in needle-design customization. It not only opens new avenues for rapid, customized design of puncture needles but also provides an innovative paradigm for intelligent design of complex medical devices, potentially advancing precision medicine technologies and shortening design cycles.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-10"},"PeriodicalIF":1.7,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144690690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-01-10DOI: 10.1080/13645706.2024.2449266
Xiaodan Zhao, Yadong Feng, Mingyue Li, Ye Zhu, Xiajiao Tang, Ruihua Shi
Background: The aim of this study was to verify the safety and efficacy of endoscopic resection (ER) for gastric gastrointestinal stromal tumors (GISTs).
Methods: Among a consecutive series of resections for gastric GISTs performed in a single center, the outcomes of patients who had ER were compared to standard surgical resection (SR).
Results: In the cohort, 329 consecutive primary localized gastric GISTs patients (n, ER/SR = 251/78) were enrolled. Patients receiving ER were revealed to have preferable post-treatment outcomes, prolonged overall survival (OS) and disease-free survival (DFS). Tumor diameter, the only independent risk factor for a complicated post-operative course, was utilized for propensity score matching (PSM). In the PSM cohort, patients receiving ER and SR with similar tumor size (4.0 [2.7-4.5] cm) shared similar aggressiveness in terms of stomach layers of tumor origination and invasion, and modified National Institutes of Health (mNIH) risk criteria. Shorter operative time, fewer economic costs, and shorter post-operative stay were still observed in the ER group (ER vs. SR: 80 [49-120] vs. 120 [98-160] minutes, p < 0.001; 44 [38-51] vs. 60 [49-84] thousand Renminbi [kRMB], p < 0.001; 7.0 [6.0-8.0] vs. 8.5 [6.0-12] days, p = 0.018, respectively). No significant difference in OS and DFS was demonstrated in the PSM cohort.
Conclusions: ER is safe and effective, thus a feasible treatment option for indicated gastric GISTs patients with the advantage of faster recovery and lower economic costs.
背景:本研究的目的是验证内镜下切除(ER)治疗胃肠道间质瘤(gist)的安全性和有效性。方法:在单一中心进行的连续一系列胃胃肠道间质瘤切除术中,将ER患者的结果与标准手术切除(SR)进行比较。结果:在队列中,329例连续的原发性局部胃gist患者(n, ER/SR = 251/78)被纳入。接受ER治疗的患者具有较好的治疗后预后,延长了总生存期(OS)和无病生存期(DFS)。肿瘤直径是术后复杂病程的唯一独立危险因素,用于倾向评分匹配(PSM)。在PSM队列中,接受ER和SR治疗的肿瘤大小相似(4.0 [2.7-4.5]cm)的患者在肿瘤起源和侵袭的胃层方面具有相似的侵袭性,并修改了美国国立卫生研究院(mNIH)的风险标准。ER组手术时间更短,经济成本更低,术后住院时间更短(ER与SR: 80 [49-120] vs. 120 [98-160] min, p p p = 0.018)。在PSM队列中,OS和DFS没有显着差异。结论:内窥镜治疗安全有效,具有恢复快、经济成本低的优势,是适应期胃间质瘤患者可行的治疗选择。
{"title":"Safety and efficacy of endoscopic resection for gastric gastrointestinal stromal tumors: a retrospective cohort study.","authors":"Xiaodan Zhao, Yadong Feng, Mingyue Li, Ye Zhu, Xiajiao Tang, Ruihua Shi","doi":"10.1080/13645706.2024.2449266","DOIUrl":"10.1080/13645706.2024.2449266","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to verify the safety and efficacy of endoscopic resection (ER) for gastric gastrointestinal stromal tumors (GISTs).</p><p><strong>Methods: </strong>Among a consecutive series of resections for gastric GISTs performed in a single center, the outcomes of patients who had ER were compared to standard surgical resection (SR).</p><p><strong>Results: </strong>In the cohort, 329 consecutive primary localized gastric GISTs patients (<i>n</i>, ER/SR = 251/78) were enrolled. Patients receiving ER were revealed to have preferable post-treatment outcomes, prolonged overall survival (OS) and disease-free survival (DFS). Tumor diameter, the only independent risk factor for a complicated post-operative course, was utilized for propensity score matching (PSM). In the PSM cohort, patients receiving ER and SR with similar tumor size (4.0 [2.7-4.5] cm) shared similar aggressiveness in terms of stomach layers of tumor origination and invasion, and modified National Institutes of Health (mNIH) risk criteria. Shorter operative time, fewer economic costs, and shorter post-operative stay were still observed in the ER group (ER vs. SR: 80 [49-120] vs. 120 [98-160] minutes, <i>p</i> < 0.001; 44 [38-51] vs. 60 [49-84] thousand Renminbi [kRMB], <i>p</i> < 0.001; 7.0 [6.0-8.0] vs. 8.5 [6.0-12] days, <i>p</i> = 0.018, respectively). No significant difference in OS and DFS was demonstrated in the PSM cohort.</p><p><strong>Conclusions: </strong>ER is safe and effective, thus a feasible treatment option for indicated gastric GISTs patients with the advantage of faster recovery and lower economic costs.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"166-176"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142951256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-01-21DOI: 10.1080/13645706.2025.2454237
Matteo Pescio, Dennis Kundrat, Giulio Dagnino
Endovascular interventions excel in treating cardiovascular diseases in a minimally invasive manner, showing improved outcomes over open techniques. However, challenges related to precise navigation - still relying on 2D fluoroscopy - persist. This review examines the role of robotics, highlighting commercial and research platforms, while exploring emerging trends like MRI compatibility, enhanced navigation, and autonomy. MRI-compatible systems offer radiation-free 3D imaging. Human-robot interaction evolves with task-specific interfaces, while autonomy ranges from partial to full, aiding clinical operators. Challenges include complexity and cost, emphasizing compatibility and navigation advancements. Integrating MRI-compatible robots, refining human-robot interaction, and enhancing autonomy promise advancements in endovascular surgery, fueled by AI and innovative imaging.
{"title":"Endovascular robotics: technical advances and future directions.","authors":"Matteo Pescio, Dennis Kundrat, Giulio Dagnino","doi":"10.1080/13645706.2025.2454237","DOIUrl":"10.1080/13645706.2025.2454237","url":null,"abstract":"<p><p>Endovascular interventions excel in treating cardiovascular diseases in a minimally invasive manner, showing improved outcomes over open techniques. However, challenges related to precise navigation - still relying on 2D fluoroscopy - persist. This review examines the role of robotics, highlighting commercial and research platforms, while exploring emerging trends like MRI compatibility, enhanced navigation, and autonomy. MRI-compatible systems offer radiation-free 3D imaging. Human-robot interaction evolves with task-specific interfaces, while autonomy ranges from partial to full, aiding clinical operators. Challenges include complexity and cost, emphasizing compatibility and navigation advancements. Integrating MRI-compatible robots, refining human-robot interaction, and enhancing autonomy promise advancements in endovascular surgery, fueled by AI and innovative imaging.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"239-252"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-02-07DOI: 10.1080/13645706.2025.2449699
Karianne Sagberg, Torgrim Lie, Helene F Peterson, Vigdis Hillestad, Anne Eskild, Lars Eirik Bø
Background: Placental volume measurements can potentially identify high-risk pregnancies. We aimed to develop and validate a new method for placental volume measurements using tracked 2D ultrasound and automatic image segmentation.
Methods: We included 43 pregnancies at gestational week 27 and acquired placental images using a 2D ultrasound probe with position tracking, and trained a convolutional neural network (CNN) for automatic image segmentation. The automatically segmented 2D images were combined with tracking data to calculate placental volume. For 15 of the included pregnancies, placental volume was also estimated based on MRI examinations, 3D ultrasound and manually segmented 2D ultrasound images. The ultrasound methods were compared to MRI (gold standard).
Results: The CNN demonstrated good performance in automatic image segmentation (F1-score 0.84). The correlation with MRI-based placental volume was similar for tracked 2D ultrasound using automatically segmented images (absolute agreement intraclass correlation coefficient [ICC] 0.58, 95% CI 0.13-0.84) and manually segmented images (ICC 0.59, 95% CI 0.13-0.84). The 3D ultrasound method showed lower ICC (0.35, 95% CI -0.11 to 0.74) than the methods based on tracked 2D ultrasound.
Conclusions: Tracked 2D ultrasound with automatic image segmentation is a promising new method for placental volume measurements and has potential for further improvement.
背景:胎盘体积测量可以潜在地识别高危妊娠。我们的目的是开发和验证一种新的方法,用于胎盘体积测量跟踪二维超声和自动图像分割。方法:选取43例妊娠第27周的孕妇,采用位置跟踪的二维超声探头获取胎盘图像,并训练卷积神经网络(CNN)进行图像自动分割。将自动分割的二维图像与跟踪数据结合计算胎盘体积。对其中15例妊娠,还根据MRI检查、3D超声和手工分割的2D超声图像估计胎盘体积。将超声方法与MRI(金标准)进行比较。结果:CNN在自动图像分割方面表现良好(F1-score 0.84)。使用自动分割图像跟踪二维超声(绝对一致类内相关系数[ICC] 0.58, 95% CI 0.13-0.84)和手动分割图像(ICC 0.59, 95% CI 0.13-0.84)与基于mri的胎盘体积的相关性相似。3D超声方法的ICC (0.35, 95% CI -0.11 ~ 0.74)低于基于二维超声跟踪的方法。结论:自动图像分割的二维超声追踪技术是一种很有前途的胎盘体积测量新方法,并有进一步改进的潜力。
{"title":"A new method for placental volume measurements using tracked 2D ultrasound and automatic image segmentation.","authors":"Karianne Sagberg, Torgrim Lie, Helene F Peterson, Vigdis Hillestad, Anne Eskild, Lars Eirik Bø","doi":"10.1080/13645706.2025.2449699","DOIUrl":"10.1080/13645706.2025.2449699","url":null,"abstract":"<p><strong>Background: </strong>Placental volume measurements can potentially identify high-risk pregnancies. We aimed to develop and validate a new method for placental volume measurements using tracked 2D ultrasound and automatic image segmentation.</p><p><strong>Methods: </strong>We included 43 pregnancies at gestational week 27 and acquired placental images using a 2D ultrasound probe with position tracking, and trained a convolutional neural network (CNN) for automatic image segmentation. The automatically segmented 2D images were combined with tracking data to calculate placental volume. For 15 of the included pregnancies, placental volume was also estimated based on MRI examinations, 3D ultrasound and manually segmented 2D ultrasound images. The ultrasound methods were compared to MRI (gold standard).</p><p><strong>Results: </strong>The CNN demonstrated good performance in automatic image segmentation (F1-score 0.84). The correlation with MRI-based placental volume was similar for tracked 2D ultrasound using automatically segmented images (absolute agreement intraclass correlation coefficient [ICC] 0.58, 95% CI 0.13-0.84) and manually segmented images (ICC 0.59, 95% CI 0.13-0.84). The 3D ultrasound method showed lower ICC (0.35, 95% CI -0.11 to 0.74) than the methods based on tracked 2D ultrasound.</p><p><strong>Conclusions: </strong>Tracked 2D ultrasound with automatic image segmentation is a promising new method for placental volume measurements and has potential for further improvement.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"230-238"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143365057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2024-12-12DOI: 10.1080/13645706.2024.2440403
Yi Chen, Zhengjie Wu
Background: Several modified endoscopic mucosal resection (EMR) techniques have been reported for colorectal tumors. Precutting-EMR (PEMR) is a modification wherein a circumferential mucosal incision is made around a lesion to facilitate en bloc resection. This review compared the efficacy and safety of PEMR with conventional EMR for colorectal lesions.
Methods: PubMed, Embase, Scopus, and Web of Science were searched for comparative studies available before February 15, 2024. This systematic review and meta-analysis were recorded in PROSPERO, identified as CRD42024509143.
Results: Two hundred and eight studies underwent screening of which seven studies were found eligible. We found no significant difference in en bloc resection rates but complete resection rates were significantly better with PEMR. The duration of the procedure was significantly longer with PEMR as compared to EMR. There was no difference in the risk of delayed bleeding and recurrence between the two groups but the risk of perforation was significantly increased with PEMR.
Conclusions: The use of PEMR for colorectal lesions can improve complete resection rates, albeit at the cost of increased duration of the procedure and higher perforation rates compared to conventional EMR. PEMR may also have a tendency of better en bloc resection rates which needs to be confirmed by further studies.
背景:有报道称,有几种改良的内镜粘膜切除术(EMR)可用于结直肠肿瘤。预切-EMR(PEMR)是一种改良技术,即在病变周围做一个环形粘膜切口,以便于进行全切。本综述比较了PEMR与传统EMR治疗结直肠病变的有效性和安全性:方法:检索了 PubMed、Embase、Scopus 和 Web of Science 上 2024 年 2 月 15 日之前的对比研究。本系统综述和荟萃分析已录入 PROSPERO,编号为 CRD42024509143:结果:共筛选出 28 项研究,其中 7 项符合条件。我们发现全块切除率没有明显差异,但完全切除率明显优于 PEMR。与EMR相比,PEMR的手术时间明显更长。两组患者发生延迟出血和复发的风险没有差异,但PEMR患者发生穿孔的风险明显增加:结论:与传统的EMR相比,使用PEMR治疗结直肠病变可提高完全切除率,但代价是手术时间延长,穿孔率升高。PEMR也有可能提高全切率,这需要进一步研究证实。
{"title":"The efficacy and safety of precutting-endoscopic mucosal resection for colorectal tumors: a systematic review and meta-analysis.","authors":"Yi Chen, Zhengjie Wu","doi":"10.1080/13645706.2024.2440403","DOIUrl":"10.1080/13645706.2024.2440403","url":null,"abstract":"<p><strong>Background: </strong>Several modified endoscopic mucosal resection (EMR) techniques have been reported for colorectal tumors. Precutting-EMR (PEMR) is a modification wherein a circumferential mucosal incision is made around a lesion to facilitate en bloc resection. This review compared the efficacy and safety of PEMR with conventional EMR for colorectal lesions.</p><p><strong>Methods: </strong>PubMed, Embase, Scopus, and Web of Science were searched for comparative studies available before February 15, 2024. This systematic review and meta-analysis were recorded in PROSPERO, identified as CRD42024509143.</p><p><strong>Results: </strong>Two hundred and eight studies underwent screening of which seven studies were found eligible. We found no significant difference in en bloc resection rates but complete resection rates were significantly better with PEMR. The duration of the procedure was significantly longer with PEMR as compared to EMR. There was no difference in the risk of delayed bleeding and recurrence between the two groups but the risk of perforation was significantly increased with PEMR.</p><p><strong>Conclusions: </strong>The use of PEMR for colorectal lesions can improve complete resection rates, albeit at the cost of increased duration of the procedure and higher perforation rates compared to conventional EMR. PEMR may also have a tendency of better en bloc resection rates which needs to be confirmed by further studies.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"177-186"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2024-11-30DOI: 10.1080/13645706.2024.2434825
Marco Oderda, Alessandro Marquis, Giorgio Calleris, Daniele D'Agate, Luisa Delsedime, Elena Vissio, Alessandro Dematteis, Marco Gatti, Riccardo Faletti, Giancarlo Marra, Gabriele Montefusco, Paolo Gontero
Background: Targeted microwave ablation (TMA) is a novel modality of focal therapy to treat localized prostate cancer (PCa). We evaluated its short-term functional and oncologic outcomes.
Method: We performed a single-center, prospective, interventional phase I-II pilot trial (NCT04627896). TMA was performed in 11 patients with a single intracapsular MRI-visible lesion ≤12 mm, International Society of Urological Pathology (ISUP) grade ≤ 2, Prostate Specific Antigen (PSA) < 20 ng/mL, and a 5-mm safety distance from apex and rectum. Patients were treated with a 12 W very low-loss microwaves ablation system, guided by 3D ultrasound/MRI fusion imaging. Follow-up consisted in clinical visits, PSA and validated questionnaires. MRI was scheduled at five months and rebiopsy at six months. The primary endpoints of study were safety and efficacy (absence of tumour in the treated area).
Results: No severe complications were reported. All patients were discharged the same day of treatment without bladder catheter. No significant changes in PSA or questionnaires scores were reported. At rebiopsy, no cancer was found in five patients (45%); eight patients (73%) had an absence of in-field PCa and nine patients (82%) had an absence of in-field ISUP ≥ 2 PCa. New cancer foci outside the treated area were found in three patients (27%). Limitations of this study were the very limited sample size, the short follow-up, and the lack of a comparator.
Conclusions: TMA guided by fusion imaging is a safe modality with good ablative efficacy.
{"title":"Transperineal 3D fusion imaging-guided targeted microwaves ablation for low to intermediate-risk prostate cancer: results of a phase I-II study.","authors":"Marco Oderda, Alessandro Marquis, Giorgio Calleris, Daniele D'Agate, Luisa Delsedime, Elena Vissio, Alessandro Dematteis, Marco Gatti, Riccardo Faletti, Giancarlo Marra, Gabriele Montefusco, Paolo Gontero","doi":"10.1080/13645706.2024.2434825","DOIUrl":"10.1080/13645706.2024.2434825","url":null,"abstract":"<p><strong>Background: </strong>Targeted microwave ablation (TMA) is a novel modality of focal therapy to treat localized prostate cancer (PCa). We evaluated its short-term functional and oncologic outcomes.</p><p><strong>Method: </strong>We performed a single-center, prospective, interventional phase I-II pilot trial (NCT04627896). TMA was performed in 11 patients with a single intracapsular MRI-visible lesion ≤12 mm, International Society of Urological Pathology (ISUP) grade ≤ 2, Prostate Specific Antigen (PSA) < 20 ng/mL, and a 5-mm safety distance from apex and rectum. Patients were treated with a 12 W very low-loss microwaves ablation system, guided by 3D ultrasound/MRI fusion imaging. Follow-up consisted in clinical visits, PSA and validated questionnaires. MRI was scheduled at five months and rebiopsy at six months. The primary endpoints of study were safety and efficacy (absence of tumour in the treated area).</p><p><strong>Results: </strong>No severe complications were reported. All patients were discharged the same day of treatment without bladder catheter. No significant changes in PSA or questionnaires scores were reported. At rebiopsy, no cancer was found in five patients (45%); eight patients (73%) had an absence of in-field PCa and nine patients (82%) had an absence of in-field ISUP ≥ 2 PCa. New cancer foci outside the treated area were found in three patients (27%). Limitations of this study were the very limited sample size, the short follow-up, and the lack of a comparator.</p><p><strong>Conclusions: </strong>TMA guided by fusion imaging is a safe modality with good ablative efficacy.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"194-202"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2024-11-15DOI: 10.1080/13645706.2024.2429069
Ali Serdar Gozen, Samet Senel, Antonios Koudonas, Fabrizio Dal Moro, Jens Rassweiler
Background: In robot-assisted radical prostatectomy (RARP), the peritoneal edges isolate the extended pelvic lymph node dissection bed from the peritoneal cavity. We studied the effect of peritoneal re-configuration through peritoneal flap fixation (PFF) with curling technique on lymphocele development.
Method: We included 2087 patients who underwent RARP between 2010 and 2022. Two hundred and thirty patients whose operation was performed using the PFF with curling technique were matched in a 1:1 ratio with non-PFF patients based on age, body mass index, initial prostate-specific antigen, and number of removed lymph nodes. Demographic, clinical, intraoperative and postoperative characteristics were collected. Complications were classified using the Clavien-Dindo system and the presence of lymphocele was documented.
Results: The two groups were similar in respect to matching parameters. Fifteen (6.5%) patients in the non-PFF group and two (0.9%) patients in the PFF group suffered from symptomatic lymphocele with symptoms such as abdominal pain, fever, lower extremity and/or genital oedema (p = 0.001). Asymptomatic lymphocele was diagnosed by ultrasonography in 19 (8.3%) patients in the non-PFF group and eight (3.5%) patients in the PFF group (p = 0.029).
Conclusion: The results of our study support this concept by providing solid indications of the clinical benefits and safety of PFF with the curling technique.
{"title":"The effect of peritoneal flap fixation with curling technique on postoperative lymphocele formation in robot-assisted radical prostatectomy.","authors":"Ali Serdar Gozen, Samet Senel, Antonios Koudonas, Fabrizio Dal Moro, Jens Rassweiler","doi":"10.1080/13645706.2024.2429069","DOIUrl":"10.1080/13645706.2024.2429069","url":null,"abstract":"<p><strong>Background: </strong>In robot-assisted radical prostatectomy (RARP), the peritoneal edges isolate the extended pelvic lymph node dissection bed from the peritoneal cavity. We studied the effect of peritoneal re-configuration through peritoneal flap fixation (PFF) with curling technique on lymphocele development.</p><p><strong>Method: </strong>We included 2087 patients who underwent RARP between 2010 and 2022. Two hundred and thirty patients whose operation was performed using the PFF with curling technique were matched in a 1:1 ratio with non-PFF patients based on age, body mass index, initial prostate-specific antigen, and number of removed lymph nodes. Demographic, clinical, intraoperative and postoperative characteristics were collected. Complications were classified using the Clavien-Dindo system and the presence of lymphocele was documented.</p><p><strong>Results: </strong>The two groups were similar in respect to matching parameters. Fifteen (6.5%) patients in the non-PFF group and two (0.9%) patients in the PFF group suffered from symptomatic lymphocele with symptoms such as abdominal pain, fever, lower extremity and/or genital oedema (<i>p</i> = 0.001). Asymptomatic lymphocele was diagnosed by ultrasonography in 19 (8.3%) patients in the non-PFF group and eight (3.5%) patients in the PFF group (<i>p</i> = 0.029).</p><p><strong>Conclusion: </strong>The results of our study support this concept by providing solid indications of the clinical benefits and safety of PFF with the curling technique.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"203-211"},"PeriodicalIF":1.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}